The Valley Desk

Clinical trial reportNature medicinePublished

Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names The Wistar Institute. Affiliation source

Publication record

Type
Clinical trial report
Venue
Nature medicine
Published
Subject terms
Humans; Carcinoma, Hepatocellular; Liver Neoplasms; Vaccines; Antibodies, Monoclonal, Humanized
PubMed ID
38584166
PubMed Central ID
PMC11031401
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal